Safety, Tolerability and Pharmacodynamics of AP214 Acetate in Patients Undergoing Cardiac Surgery

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
The purpose of the present research study is to investigate for the first time, the safety and tolerability of infusion doses of AP214 in subjects having heart surgery such as coronary bypass graft and/or valve repair or replacement surgery. AP214, the investigational drug, is being developed to potentially prevent post-surgical kidney injury after thoracic aortic aneurysm repair.
Epistemonikos ID: c6b41d9b2f41d85df2631723d5eff6b13f9929f3
First added on: May 04, 2024